Anti-CD20 therapy was associated with lower response rates, and anti-tumor necrosis factor showed a trend toward lower response rates in a multivariable metaregression.
1
—
—
Anti-CD20 therapy was associated with lower response rates, and anti-tumor necrosis factor showed a trend toward lower response rates in a multivariable metaregression.